In blood samples of patients with operable non-small cell lung cancer (NSCLC), preoperative survivin mRNA positivity correlated with a worse prognosis, decreased survivin mRNA levels were measured after surgical resection, and still positive postoperative survivin mRNA indicated more frequent tumor recurrence and shorter disease-free and overall survival [17]. This evidence concerns the gene BIRC5 and non-small cell lung carcinoma.